2022
Treatment of axial spondyloarthritis: an update
Danve A, Deodhar A. Treatment of axial spondyloarthritis: an update. Nature Reviews Rheumatology 2022, 18: 205-216. PMID: 35273385, DOI: 10.1038/s41584-022-00761-z.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2017
Treat to Target in Axial Spondyloarthritis: What Are the Issues?
Danve A, Deodhar A. Treat to Target in Axial Spondyloarthritis: What Are the Issues? Current Rheumatology Reports 2017, 19: 22. PMID: 28386759, DOI: 10.1007/s11926-017-0648-6.Peer-Reviewed Original ResearchMeSH KeywordsAntirheumatic AgentsBiological ProductsDrug MonitoringEarly DiagnosisHumansSeverity of Illness IndexSpondylarthritisTreatment OutcomeConceptsT2T strategyAxial spondyloarthritisT2TPsoriatic Arthritis TrialRandomized clinical studyChronic medical conditionsLimited therapeutic optionsRoutine clinical practiceT strategyLack of evidenceAggressive managementPsoriatic arthritisRadiographic outcomesRheumatic diseasesRheumatoid arthritisClinical evidenceTherapeutic optionsArthritis trialsClinical trialsClinical studiesMedical conditionsClinical practiceTarget strategyArthritisSpondyloarthritis